These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3904651)

  • 21. CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacology.
    Ryan MJ; Bjork FA; Cohen DM; Coughenour LL; Major TC; Mathias NP; Mertz TE; Olszewski BJ; Singer RM; Evans DB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):473-9. PubMed ID: 2874210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a new antihypertensive agent, SGB-1534, on rat platelet aggregation.
    Aono J; Sakai K
    Jpn J Pharmacol; 1986 Dec; 42(4):493-500. PubMed ID: 2879951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute antihypertensive effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)-carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitrophen yl) octyl ester on conscious spontaneously hypertensive rats and renal hypertensive rats.
    Hojo M; Tanaka Y; Katayama O; Teramoto N
    Arzneimittelforschung; 1993 Aug; 43(8):847-51. PubMed ID: 8216440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel alpha 1-adrenoceptor antagonist, in rats.
    Aono J; Sakai K
    Jpn J Pharmacol; 1988 Oct; 48(2):229-39. PubMed ID: 2905394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
    Hefti F; Clozel JP; Osterrieder W
    Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative.
    Masuda Y; Takeguchi M; Arakawa C; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1990; 304():247-64. PubMed ID: 2241414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative first dose effects of prazosin and tiodazosin (BL-5111) in spontaneously hypertensive rats.
    Roebel LE; Florczyk AP; Buyniski JP
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):29-35. PubMed ID: 441514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
    Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
    Nakajima T; Shinohara T; Yaoka O; Fukunari A; Shinagawa K; Aoki K; Katoh A; Yamanaka T; Setoguchi M; Tahara T
    J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive activity of tibalosine (CP 804 S) in the rat. Possible involvement of a central alpha 1-adrenergic receptor blockade.
    Chatelain P; Claeys M; van Dorsser W; Roba J
    Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):271-86. PubMed ID: 6145397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.
    Roesler JM; McCafferty JP; DeMarinis RM; Matthews WD; Hieble JP
    J Pharmacol Exp Ther; 1986 Jan; 236(1):1-7. PubMed ID: 2867209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats.
    Morita T; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1047-52. PubMed ID: 6890824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a novel alpha 1-adrenoceptor antagonist, SGB-1534, in contractile response of isolated canine arterial and venous smooth muscle to exogenous noradrenaline: comparison with prazosin, phentolamine and yohimbine.
    Koga T; Shiraki Y; Sakai K
    Jpn J Pharmacol; 1989 Jun; 50(2):185-93. PubMed ID: 2570173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive drugs: their postural hypotensive effect and their blood pressure lowering activity in conscious normotensive rats.
    Lee CH; Strosberg AM; Carver LA
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):90-101. PubMed ID: 6342560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular effect of a novel substance, 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl] ethyl]-2,4 (1H, 3H)-quinazolinedione monohydrochloride (SGB 1534)].
    Uchida Y; Sugimoto T
    Nihon Yakurigaku Zasshi; 1985 Jun; 85(6):447-51. PubMed ID: 2863201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities.
    Kubo M; Kato J; Ochiai T; Ishida R
    Jpn J Pharmacol; 1990 Jun; 53(2):201-10. PubMed ID: 2200918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.